ACKNOWLEDGEMENTS: Whenever we get on with a job, we need support in many ways. Quite often, we get the support we require. When I sat down to complete this project, I was…

1. Stephanie Nishi Spencer Lee Andrew Walnum Gurmeet Marwaha Period 5, Biotechnology 2. The Scenario What can Biotex offer this scientist in order to avoid going out of business?…

Slide 11 FDA CLINICAL TRIAL REQUIREMENTS FOR MEDICAL DEVICES NEIL F. OFLAHERTY PRINCIPAL OLSSON FRANK WEEDA TERMAN BODE MATZ PC MEDICAL DEVICE CLINICAL RESEARCH AND REIMBURSEMENT…

Slide 1Food and Drug Administration Center for Biologics Evaluation and Research The Office of Cellular, Tissue, and Gene Therapies Web Seminar Series presents: The Office…

Slide 11 FDA’s BIMO Inspection Program and IRB Inspections VA IRB Chairs Meeting August 2012 Janet Donnelly RAC, CIP Office of Good Clinical Practice Office of the Commissioner…

1. “The Facility’s Perspective” (FDA) Inspections 2. The SpeakerPatrick R. Ayd RN, MBA2 3. The Facility‘s PerspectiveHow to prepare for an FDA Inspection Understanding…

1. Outsourcing to an AAHRPP-Accredited IRB vs.Creating a Local, Regulatory-Compliant IRBAugust 22, 2012 2. Today’s Speakers: Lynn Smith Manager, Huron Life Sciences P 312…

PowerPoint Presentation The Declaration of Helsinki 1964 - Adopted by the 18th World Medical Assembly (latest version 2008) A notable change from the Nuremberg Code was a…

Slide 1ORIENTATION FOR NEW CLINICAL RESEARCH PERSONNEL MODULE 2 Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research Professionals…

Slide 1VA Requirements for Vulnerable Subjects Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE) Slide…